Looking at the raw quarterly tape first: revenue has actually been declining sequentially from $30.58B (Oct 2024) to $27.02B (Apr 2026) — a ~12% top-line contraction over six quarters that the "steady-compounder" narrative glosses over. Net income is noisier still: the April 2025 quarter shows $11.13B (39.1% margin), which is almost certainly the Schwab stake divestiture gain, not operating earnings. Strip that out and underlying quarterly NI is running $3.0–4.3B, with the two most recent prints ($4.05B, $4.25B) showing genuine sequential improvement in margin (11.4% → 14.4% → 15.7%). That's the actual signal: revenue is shrinking but profitability per dollar is recovering as AML remediation costs normalize and the U.S. retail growth cap forces discipline. The headline 39% "earnings CAGR" and 132% YoY are arithmetic artifacts of the Schwab gain and the -$181M Jul-2024 charge — both should be ignored.

On valuation: the 18.9x TTM P/E cited in the canonical metrics conflicts with the synthesis model's repeated claim of "10.3x." The 10.3x figure is forward/normalized and excludes one-timers; the 18.9x trailing includes the lumpy quarters. Reality is somewhere around 11–12x normalized — which is roughly in line with, not a discount to, RY (~14x) and BMO (~13x) given TD's growth-restriction overhang. P/B of 1.54x is also middle-of-pack for Canadian banks, not cheap. The 3.88% dividend yield is the real anchor here; at a ~50% payout that's sustainable but offers no margin of safety versus 5-year GICs at ~4%. ROE of 11.85% is sub-peer (RY ~16%, BMO ~12%) and ROIC of 1.65% (even adjusting for bank accounting quirks where this metric is largely meaningless) reflects the capital-trapped reality of the U.S. asset cap.

Where I dissent from the prior models: the synthesis verdict of "Reasonable Premium" and the narrative layer's "durable steady-compounder" both underweight the structural problem. The OCC asset cap on TD's U.S. retail bank is not a transient compliance issue — it's a multi-year ceiling on what was supposed to be the growth engine. Until it's lifted (no clear timeline), TD is structurally a Canadian-domestic bank with a frozen U.S. subsidiary, and Canadian banking is a 4–5% nominal growth oligopoly. The 6.4% revenue CAGR is backward-looking and inflated by the 2022→2023 jump (likely First Horizon-related accounting before the deal broke). Forward revenue growth is probably 2–4%, EPS growth maybe 5–7% with buybacks. That doesn't justify a premium to peers; it argues for a discount, which is roughly where it trades. The contrarian case: TD is a value trap dressed as a recovery story — the stock has rallied ~50% off lows on hope of asset-cap relief, and if the OCC drags this into 2027, multiple compression resumes.

Data quality concerns worth flagging: operating cash flow of -$69.65B and FCF of -$71.79B are meaningless for a bank (deposit/loan flow timing) and the "Poor Cash Flow Quality" secondary signal should be discarded entirely. Total debt and equity blanks in the balance sheet section make independent leverage analysis impossible from this file. Insider activity is stale (last meaningful print Dec 2023) and tiny — no signal either way. The Market Forces module failed to run, so we have no read on flows or positioning. Given all that, I land close to but slightly below the synthesis "Reasonable Premium" verdict: TD at $119.62 is fairly valued to modestly rich for what it is — a capital-constrained, slow-growth Canadian bank with a frozen U.S. arm, paying a 3.88% dividend. Fair value is roughly $105–115 on normalized 10–11x ~$10.50 forward EPS. The asymmetry isn't there: upside requires OCC relief (binary, unknowable timing), downside is multiple compression to 9x if Canadian housing cracks or NIM compresses further. Own it for the dividend if you must, but don't expect alpha.